Stocktoria
InfuSystem Holdings, Inc INFU
NYSE American · XASE · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2006-06-15
InfuSystem Holdings, Inc financials (annual, from 10-K)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $143.4M | $134.9M | $125.8M | $109.9M | $102.4M | $97.4M | $81.1M | $67.1M | $71.1M | $70.5M |
| Gross profit | $80.3M | $70.4M | $63.1M | $60.6M | $58.5M | $58.8M | $46.9M | $39.6M | $43.4M | $44.7M |
| Operating income | $11.9M | $6.9M | $4.1M | $1.7M | $2.8M | $8.8M | $3.5M | $415,000 | -$3.8M | $974,000 |
| Interest expense | — | — | $2.2M | $1.4M | $1.4M | $1.3M | $1.9M | $1.4M | $1.3M | $1.3M |
| Income tax | $4.0M | $2.7M | $979,000 | $112,000 | -$163,000 | -$9.8M | $163,000 | $53,000 | $15.4M | -$142,000 |
| Net income | $6.6M | $2.3M | $872,000 | $18,000 | $1.4M | $17.3M | $1.4M | -$1.1M | -$20.7M | -$222,000 |
| EPS (diluted) | $0.31 | $0.11 | $0.04 | $0.00 | $0.06 | $0.80 | $0.07 | $-0.05 | $-0.91 | $-0.01 |
| Operating cash flow | $24.4M | $20.5M | $11.2M | $17.5M | $18.3M | $20.3M | $13.9M | $11.4M | $7.7M | $7.9M |
| Free cash flow | $23.8M | $19.4M | $10.2M | $16.5M | $17.3M | $19.2M | $10.9M | $11.1M | $7.6M | $7.7M |
| Cash & equivalents | $3.2M | $527,000 | $231,000 | $165,000 | $186,000 | $9.6M | $2.6M | $4.3M | $3.5M | $3.4M |
| Inventory | $5.4M | $6.5M | $6.4M | $4.8M | $3.9M | $3.0M | $2.9M | $2.3M | $1.8M | $2.2M |
| Total assets | $100.6M | $103.6M | $102.9M | $99.4M | $97.6M | $97.0M | $79.2M | $64.1M | $68.9M | $96.3M |
| Total liabilities | $43.2M | $46.1M | $50.6M | $51.4M | $49.3M | $56.2M | $56.9M | $43.6M | $37.9M | $45.7M |
| Shareholders' equity | $57.3M | $57.5M | $52.3M | $48.0M | $48.3M | $40.8M | $22.3M | $20.4M | $31.0M | $50.7M |
Growth · year-over-year · Revenue CAGR 8.2%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +6.4% | +7.2% | +14.4% | +7.4% | +5.1% | +20.1% | +20.8% | -5.5% | +0.8% | -0.1% |
| Net income growth | +182.6% | +168.9% | +4744.4% | -98.7% | -91.8% | +1173.5% | — | — | — | -108.0% |
| EPS growth | +181.8% | +175.0% | — | -100.0% | -92.5% | +1042.9% | — | — | — | -108.3% |
| Free cash flow growth | +23.1% | +89.9% | -38.3% | -4.6% | -9.6% | +75.2% | -1.4% | +45.9% | -1.6% | +14.9% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0001337013 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.